
Biotechnology
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has announced that it is entering a royalty agreement with HealthCare Royalty Partners, boosting KPTI stock. Karyopharm, a Massachusettes-based pharmaceutical firm, will receive an initial $75 million USD by the end of ... [Read]